학술논문
miR-100-5p confers resistance to ALK tyrosine kinase inhibitors Crizotinib and Lorlatinib in EML4-ALK positive NSCLC
Document Type
Article
Author
Source
In: Biochemical and Biophysical Research Communications . (Biochemical and Biophysical Research Communications, 2 April 2019, 511(2):260-265)
Subject
Language
English
ISSN
10902104
0006291X
0006291X